Anti-IL-17A (clone LC2EC1G) SynExpress la-Cy3-cJ-K Modified CD8+ T cells
CAT#: ITS-1224-CR78
Clone: LC2EC1G
Host: Human
Cell Source: Modified CD8+ T cells
Species Reactivity: Human; Cynomolgus monkey
Connector Fragments: lac-Cy3-c-Jun-KpnI
Carrier Type: pUC
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target IL-17A (clone LC2EC1G). We employs the pUC (lac-Cy3-c-Jun-KpnI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Negative feedback for a robust and sustained response against cancers.
All cell products are transported using dry ice, or specialized refrigerated containers to ensure that their temperature remains within an appropriate range. For cell products that are particularly sensitive to temperature, transportation must be carried out in liquid nitrogen tanks to ensure the quality and viability of the products.
Handling Advice
Handle cells in a sterile environment to prevent contamination. Use aseptic techniques when transferring to new media or containers. Follow biosafety regulations for disposing of cell waste.
Storage
Keep cell products in the designated temperature range (usually liquid nitrogen or -80°C) to maintain viability.